FIELD: medicine, ophthalmology.
SUBSTANCE: one should introduce 10 ml 0.1%-serotonin adipinate twice daily for 10 d parenterally. The innovation enables to achieve rapid resorption of blood in ocular cavity after the hemorrhage occurred due to deblocking serotonin receptors against hemoglobin that provides normalization of microcirculation in choroidea and retina along with reconstructing inflow-outflow of intraocular liquid in ocular cavity.
EFFECT: higher efficiency of therapy.
2 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING INTRAOCULAR HEMORRHAGES | 0 |
|
SU1018634A1 |
| METHOD FOR MODELING CHRONIC SEROTONIN INSUFFICIENCY | 2004 |
|
RU2263975C1 |
| METHOD OF SECONDARY POST-TRAUMATIC INTRAOCULAR HEMORRHAGE FORECAST | 2007 |
|
RU2349251C1 |
| METHOD FOR CARRYING OUT CONTROLLABLE PROTEOLYTIC ENZYMOTHERAPY OF INTRAOCULAR HEMORRHAGES OF TRAUMATIC GENESIS | 2006 |
|
RU2307629C1 |
| METHOD OF CONSERVATIVE TREATMENT OF RECURRENT HAEMOPHTHALMIA IN DIABETIC RETINOPATHY | 2012 |
|
RU2485944C1 |
| METHOD FOR TREATING THE CASES OF HEMOPHTHALMIA | 2000 |
|
RU2180204C2 |
| METHOD FOR DIABETIC RETINOPATHY WITH EXUDATIVE-HEMORRHAGIC MACULOPATHY ACCOMPANIED BY HYPOCOAGULATION AND HEMORRHAGIC SYNDROME | 2003 |
|
RU2245140C1 |
| ANTIHEMORRHAGIC AGENT FOR RESOLVING INTRAOCULAR HEMORRHAGE | 0 |
|
SU1537247A1 |
| PHARMACEUTICAL COMPOSITION ELICITING THROMBOLYTIC AND FIBRINOLYTIC EFFECT | 2002 |
|
RU2216348C1 |
| METHOD OF TREATING HEMOPHTHALMIA | 2009 |
|
RU2422120C1 |
